Trial Profile
A Phase II Study of Pazopanib in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Refractory to Platinum-Based Chemotherapy
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 04 Nov 2023
Price :
$35
*
At a glance
- Drugs Pazopanib (Primary)
- Indications Head and neck cancer
- Focus Therapeutic Use
- 23 Jun 2011 New trial record